Purchases and Sales Made in Q1 2022 in Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO) during Q1 2022. The information is specifically focused on institutions that hold shares of AGIOS PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Ubs Group Ag
|
SELL
|
- |
-140K- 75.27% |
$3.72M - $4.86M
|
45.9K
$1.58M
|
|
|
Feb 14, 2023
Q1 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-161K- 44.47% |
$4.29M - $5.6M
|
201K
$6.91M
|
|
|
May 16, 2022
Q1 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-177K- 6.15% |
$4.72M - $6.16M
|
2.7M
$93M
|
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-206KClosed |
$5.49M - $7.16M
|
0
$0
|
|
|
May 12, 2022
Q1 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-207K- 3.82% |
$5.51M - $7.19M
|
5.2M
$179M
|
|
|
May 13, 2022
Q1 2022
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-220K- 5.06% |
$5.87M - $7.66M
|
4.13M
$142M
|